title: Antiallodynic effects produced by stimulation of the periaqueductal gray matter in a rat model of neuropathic pain.
abstract: It has been well documented that there is opioid resistance in neuropathic pain. This indicates that the endogenous opioid system may not be involved effectively in modulating neuropathic pain. The present study sought to determine if activation of the descending pain inhibition system might produce analgesia in the animal neuropathic model we developed. Under ketamine anesthesia, male Sprague-Dawley rats were chronically implanted with stimulating electrodes in the ventral periaqueductal gray matter (PAG) and both the tibial and sural nerves of the sciatic nerve branches were severed. Pain sensitivity was measured with a von Frey filament and acetone applied to the sensitive area for 1 week postoperatively. Rats with neuropathic pain syndrome after transection of the tibial and sural nerves were tested as to the analgesic effects of ventral PAG stimulation for an additional two weeks. Electrical stimulation of the ventral PAG turned out to be highly effective in alleviating neuropathic pain. Mechanical allodynia and cold allodynia were reduced by PAG stimulation. Naloxone reversed the antiallodynic effects of ventral PAG stimulation. These results suggest that activation of the descending pain inhibition system including the ventral PAG reduces neuropathic pain syndrome and that opiates are involved in this system.
authors.affiliation: Medical Research Center, Yonsei University College of Medicine, CPO Box 8044, 120-752, Seoul, South Korea.
authors.forename: B H
authors.initials: BH
authors.lastname: Lee
authors.forename: S H
authors.initials: SH
authors.lastname: Park
authors.forename: R
authors.initials: R
authors.lastname: Won
authors.forename: Y G
authors.initials: YG
authors.lastname: Park
authors.forename: J H
authors.initials: JH
authors.lastname: Sohn
mesh_terms: D000698:Analgesia / Q000379:methods*; D000818:Animals; D019771:Axotomy; D003080:Cold Temperature; D004195:Disease Models, Animal; D004599:Electric Stimulation Therapy / Q000379:methods*; D004567:Electrodes, Implanted; D006930:Hyperalgesia / Q000209:etiology; D008297:Male; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D010147:Pain Measurement / Q000187:drug effects; D017288:Pain Threshold / Q000187:drug effects; D010487:Periaqueductal Gray / Q000502:physiology*; D010812:Physical Stimulation; D051381:Rats; D017207:Rats, Sprague-Dawley; D020426:Sciatic Neuropathy / Q000628:therapy*; D013497:Sural Nerve / Q000502:physiology; D013979:Tibial Nerve / Q000502:physiology
chemical_list: D009292:Narcotic Antagonists; D009270:Naloxone